- Home
- FIVN vs IMTX Comparison
FIVN vs IMTX Comparison
Compare FIVN & IMTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | FIVN | IMTX |
|---|---|---|
| Founded | 2001 | N/A |
| Country | United States | Germany |
| Employees | N/A | 423 |
| Industry | EDP Services | Biotechnology: Biological Products (No Diagnostic Substances) |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.4B | 1.4B |
| IPO Year | 2014 | N/A |
Fundamental Metrics
Financial Performance| Metric | FIVN | IMTX |
|---|---|---|
| Price | $15.71 | $9.21 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 19 | 5 |
| Target Price | ★ $26.32 | $19.25 |
| AVG Volume (30 Days) | ★ 2.7M | 447.4K |
| Earning Date | 05-21-2026 | 01-01-0001 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 364.71 | N/A |
| EPS | ★ 0.45 | N/A |
| Revenue | ★ $1,149,088,000.00 | N/A |
| Revenue This Year | $11.39 | $1.92 |
| Revenue Next Year | $10.00 | $15.88 |
| P/E Ratio | $36.13 | ★ N/A |
| Revenue Growth | ★ 10.28 | N/A |
| 52 Week Low | $15.70 | $3.30 |
| 52 Week High | $31.75 | $12.41 |
Technical Indicators
Market Signals| Indicator | FIVN | IMTX |
|---|---|---|
| Relative Strength Index (RSI) | 36.61 | 40.66 |
| Support Level | N/A | $8.72 |
| Resistance Level | $20.04 | $10.64 |
| Average True Range (ATR) | 0.90 | 0.58 |
| MACD | -0.17 | -0.09 |
| Stochastic Oscillator | 0.00 | 5.35 |
Price Performance
Historical ComparisonAbout FIVN Five9 Inc.
Five9 offers cloud-native contact center software enabling digital customer service, sales, and marketing engagement. The company's Intelligent CX platform combines core telephony functionality, omnichannel engagement, and modules into a cloud contact-center-as-a-service, or CCaaS, platform. Five9's modules include digital self-service, agent assist technology, workflow automation, and optimization solutions, as well as artificial intelligence-driven automation solutions that optimize customer service efficiency and manage interaction quality and agent performance.
About IMTX Immatics N.V.
Immatics NV is a biotechnology company engaged in the research and development of T-cell redirecting immunotherapies for the treatment of cancer patients. The company earns revenue through strategic collaboration agreements with third-party pharmaceutical and biotechnology companies. The company derives its maximum revenue from United States.